Webinar Replay: Dual Target Methods for Go/No-Go Decision Making

Posted by Cytel

Oct 31, 2017 10:42:00 AM

Multicolored abstract with radial blur centered at lower right, for decoration and backgrounds with motifs of origin, energy, convergence.jpeg

As part of Cytel's new Trial Innovations Webinar Series, Pat Mitchell, Statistical Science Director at AstraZeneca presented the October webinar "Formal Go/No-Go decisions are a key component of risk management in early clinical development."

Formal Go/No-Go decisions are a key component of early clinical development risk management. Pat revealed the advantages and challenges when pre-defining prospective decision criteria in the trial design to better inform verdicts on a program's fate. Pat went on to survey the current approaches utilizing dual targets in both frequentist and Bayesian frameworks.

Missed the Webinar, but interested in learning more?

Click below and enter your details to watch the replay of the presentation and access the slide deck.

Replay Webinar

2018 Trial Innovations Webinar Series

The series of webinars will resume in 2018. Be sure to follow Cytel on LinkedIn for updates. 

 

Further reading

Case Study:

Improving Go/No Decision Making Custom Software

Blogs

Bayesian Approaches in Clinical Trials Updates on Tools Techniques

Bayesian Approaches in Benefit Risk Assesment

 

Topics: Trial Design, Adaptive Clinical Trials, phase 2, go-no-go, clinical development, adaptive designs, Bayesian, custom software

The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.  Sign up for updates direct to your inbox. You can unsubscribe at any time.

 

Posts by Topic

see all

Recent Posts